Index | Low group (n = 184) | Middle group (n = 193) | High group (n = 147) | F/χ2 | P |
---|---|---|---|---|---|
Age | 52.62 ± 8.7 | 60.26 ± 10.60 | 72.90 ± 9.98 | 178.591 | < 0.001 |
Gender | 180.232 | < 0.001 | |||
Female | 1 (1.2%) | 19 (3.6%) | 83 (15.8%) | ||
Male | 183 (34.9%) | 174 (33.2%) | 64 (12.2%) | ||
LVEF | 59.58 ± 10.0 | 57.26 ± 10.42 | 56.14 ± 10.0 | 2.892 | 0.056 |
LDL-C | 3.10 ± 0.86 | 2.93 ± 0.92 | 2.83 ± 1.00 | 3.038 | 0.048 |
BNP | 605.6 (219.3–1214.3) | 944.8 (381.2–1905) | 2302.7 (1019.5–4585.5) | 86.382 | < 0.001 |
LP(a) | 14.6(9.1–30) | 13.8(8–27.2) | 16.9(10.5–31.9) | 3.621 | 0.167 |
Hypertension | 55 (10.5%) | 128 (24.4%) | 109 (20.8%) | 80.289 | < 0.001 |
Hyperlipidemia | 153 (29.2%) | 163 (31.1%) | 119 (22.7%) | 0.978 | 0.645 |
Diabetes | 21 (4.0%) | 85 (16.2%) | 73 (13.9%) | 68.894 | < 0.001 |
TIA | 0 (0%) | 9 (1.7%) | 48 (9.2%) | 109.581 | < 0.001 |
Atrial fibrillation | 2 (0.4%) | 9 (1.7%) | 15 (2.86%) | 15.253 | < 0.001 |
Killip | |||||
1 | 151 (28.8%) | 91 (17.4%) | 40 (7.6%) | 138.958 | < 0.001 |
2 | 30 (5.7%) | 89 (17.0%) | 73 (14.0%) | ||
≥ 3 | 3 (0.6%) | 13 (2.5%) | 34 (6.5%) | ||
History of PCI | 9 (1.7%) | 7 (1.3%) | 5 (1.0%) | 0.582 | 0.762 |